VEGFA and retinopathy of prematurity: Zone 1 disease and A-ROP were more common in the anti-VEGF group than LPC group, with 38.1% (51 patients) versus 5.8% (13 patients) for zone 1 and 36.6% (49 patients) versus 4.5% (10 patients) for A-ROP (p<0.001 for both).